Kobayashi Pharmaceutical Co., Ltd.: Business Overview, Financials & Competitive Analysis
Kobayashi Pharmaceutical Co., Ltd. scores 5/10 on the AskCyborg Cyborg Score (Mixed). Established consumer health company with global expansion ambitions, but recent profitability challenges and elevated dividend payout ratios warrant cautious positioning. Dividend yield was 1.92% in 2025 with a notably high payout ratio of 211.46%, compared to 1.64% and 75.32% the prior year, suggesting profitability pressures. Recent financial results.
What is Kobayashi Pharmaceutical Co., Ltd.'s industry? Kobayashi Pharmaceutical Co., Ltd. (kobayashi.co.jp) operates in OTC Pharmaceuticals & Consumer Health Products. AskCyborg classifies Kobayashi Pharmaceutical Co., Ltd. under OTC Pharmaceuticals & Consumer Health Products in its company registry.
Kobayashi Pharmaceutical manufactures and sells OTC pharmaceuticals, quasi-drugs, deodorizing air fresheners, and sanitary products in Japan, the United States, and internationally. Founded in 1886 and headquartered i...
Cyborg Score thesis
Established consumer health company with global expansion ambitions, but recent profitability challenges and elevated dividend...
Read the full analyst-debate transcript →Get the Latest Kobayashi Pharmaceutical Co., Ltd. Report
Up-to-date AI-powered research, analyst debate audio & saved-company playlists
Get Current Report FreeKobayashi Pharmaceutical Co., Ltd. Overview
Pro stress-test →Kobayashi Pharmaceutical manufactures and sells OTC pharmaceuticals, quasi-drugs, deodorizing air fresheners, and sanitary products in Japan, the United States, and internationally. Founded in 1886 and headquartered in Osaka, Japan, the company has established a diversified consumer health and household products portfolio spanning over a century.
Strategic Profile
Pro stress-test →The company's strategic focus is on expanding its global presence, leveraging its strong domestic reputation to build brand recognition in international markets. Kobayashi Pharmaceutical is recognized for its innovative approach to product development, regularly introducing new offerings that respond to changing consumer needs.
Competitive Landscape
Pro stress-test →Kobayashi Pharmaceutical competes in Japan's OTC pharmaceutical and household products market against both established domestic manufacturers and international players. The company's 140-year heritage and brand recognition provide competitive advantages, but it faces pricing pressures and margin compression typical of the consumer health industry.
Industry Context
Kobayashi Pharmaceutical Co., Ltd. operates in OTC Pharmaceuticals & Consumer Health Products.
Key facts
Founded: 1886 · Headquarters: Osaka, Japan · Revenue: ¥53.70B (last quarter), annual estimated ~¥214.8B · Market cap: ¥427.89B-444.1B (~$2.9B-3.0B USD)